Torys represented Swift Medical on the deal. Swift Medical announced a US$35 million Series B financing. The investment round was led by Virgo Investment Group LLC...
Swift Medical’s US$35 Million Series B Financing
IntelGenx’s Strategic Partnership with atai Life Sciences
Torys LLP represented atai on the deal. McCarthy Tetrault LLP assisted IntelGenx . On May 14, 2021, IntelGenx Technologies Corp. (“IntelGenx”), a leader in pharmaceutical films completed...
SeaSpine’s $110 Million Acquisition of 7D Surgical
Torys LLP represented 7D Surgical on the transaction. On May 20, 2021, SeaSpine Holdings Corporation announced the closing of the previously announced acquisition of all of...
SeaSpine’s $110 Million Acquisition of 7D Surgical
Torys LLP represented 7D Surgical on the transaction. On May 20, 2021, SeaSpine Holdings Corporation announced the closing of the previously announced acquisition of all of...
Alpha-9 Theranostics’ C$11 Million Series A Financing
Torys LLP represented Longitude Capital on the transaction. On April 28, 2021, Alpha-9 Theranostics Inc. announced an C$11 million Series A financing to advance a portfolio...
Cardiol Therapeutics’ C$22 Million Bought Deal Offering
Torys LLP represented the syndicate of underwriters in connection with Cardiol Therapeutics offering. On May 12, 2021, Cardiol Therapeutics Inc. announced its completed bought deal public...
AmacaThera’s C$10.3 Million Series A Financing
Torys LLP epresented AmacaThera in the offering. On February 22, 2021, AmacaThera Inc. announced that it completed an oversubscribed C$10.3 million Series A financing to support...